Telephone Health Coaching and Remote Exercise Monitoring (TeGeCoach) in Peripheral Arterial Occlusive Disease
Standard
Telephone Health Coaching and Remote Exercise Monitoring (TeGeCoach) in Peripheral Arterial Occlusive Disease : A Randomized Controlled Trial. / Rezvani, Farhad; Heider, Dirk; König, Hans-Helmut; Herbarth, Lutz; Steinisch, Patrick; Schuhmann, Franziska; Böbinger, Hannes; Krack, Gundula; Korth, Thomas; Thomsen, Lara; Chase, Daniela Patricia; Schreiber, Robert; Alscher, Mark-Dominik; Finger, Benjamin; Härter, Martin; Dirmaier, Jörg.
In: DTSCH ARZTEBL INT, Vol. 121, No. 10, 17.05.2024, p. 323-330.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Telephone Health Coaching and Remote Exercise Monitoring (TeGeCoach) in Peripheral Arterial Occlusive Disease
T2 - A Randomized Controlled Trial
AU - Rezvani, Farhad
AU - Heider, Dirk
AU - König, Hans-Helmut
AU - Herbarth, Lutz
AU - Steinisch, Patrick
AU - Schuhmann, Franziska
AU - Böbinger, Hannes
AU - Krack, Gundula
AU - Korth, Thomas
AU - Thomsen, Lara
AU - Chase, Daniela Patricia
AU - Schreiber, Robert
AU - Alscher, Mark-Dominik
AU - Finger, Benjamin
AU - Härter, Martin
AU - Dirmaier, Jörg
PY - 2024/5/17
Y1 - 2024/5/17
N2 - BACKGROUND: Supervised exercise programs are used to treat intermittent claudication (IC). Home-based exercise programs have been developed to lower barriers to participation. We studied the effects of one such exercise program (TeGeCoach) on self-reported walking ability in patients with IC.METHODS: In a pragmatic multicenter randomized controlled trial (registration number NCT03496948), 1982 patients with symp - tomatic IC insured by one of three German statutory health insurance funds received either telephone health coaching with remote exercise monitoring (TeGeCoach; n = 994) or routine care (n = 988). The primary outcome was the change in Walking Impairment Questionnaire (WIQ) scores after 12 and 24 months in the intention-to-treat population. The secondary outcomes were healthrelated quality of life, symptoms of depression or anxiety, health competence, patient activation, alcohol use, and nicotine depen - dence.RESULTS: There was a significant group difference in WIQ score in favor of TeGeCoach (p < 0.0001), amounting to 6.30 points at 12 months (Bonferroni-corrected 95% CI [4.02; 8.59], Cohen's d = 0.26) and 4.55 points at 24 months ([2.20; 6.91], d = 0.19). Some of the secondary outcomes also showed positive results in favor of TeGeCoach at 12 months with small effect sizes (d ≥ 0.20), including physical health-related quality of life and patient activation. The average daily step count was not higher in the TeGeCoach group.CONCLUSION: Significant improvements regarding symptom burden demonstrate the benefit of a home-based exercise program and thus expand the opportunities for guideline-oriented treatment of IC. Future studies should additionally address the effect of home-based exercise programs on clinical variables by means of, for example, the 6-minute walk test.
AB - BACKGROUND: Supervised exercise programs are used to treat intermittent claudication (IC). Home-based exercise programs have been developed to lower barriers to participation. We studied the effects of one such exercise program (TeGeCoach) on self-reported walking ability in patients with IC.METHODS: In a pragmatic multicenter randomized controlled trial (registration number NCT03496948), 1982 patients with symp - tomatic IC insured by one of three German statutory health insurance funds received either telephone health coaching with remote exercise monitoring (TeGeCoach; n = 994) or routine care (n = 988). The primary outcome was the change in Walking Impairment Questionnaire (WIQ) scores after 12 and 24 months in the intention-to-treat population. The secondary outcomes were healthrelated quality of life, symptoms of depression or anxiety, health competence, patient activation, alcohol use, and nicotine depen - dence.RESULTS: There was a significant group difference in WIQ score in favor of TeGeCoach (p < 0.0001), amounting to 6.30 points at 12 months (Bonferroni-corrected 95% CI [4.02; 8.59], Cohen's d = 0.26) and 4.55 points at 24 months ([2.20; 6.91], d = 0.19). Some of the secondary outcomes also showed positive results in favor of TeGeCoach at 12 months with small effect sizes (d ≥ 0.20), including physical health-related quality of life and patient activation. The average daily step count was not higher in the TeGeCoach group.CONCLUSION: Significant improvements regarding symptom burden demonstrate the benefit of a home-based exercise program and thus expand the opportunities for guideline-oriented treatment of IC. Future studies should additionally address the effect of home-based exercise programs on clinical variables by means of, for example, the 6-minute walk test.
KW - Aged
KW - Arterial Occlusive Diseases/therapy
KW - Exercise Therapy/methods
KW - Female
KW - Germany
KW - Humans
KW - Intermittent Claudication/therapy
KW - Male
KW - Mentoring/methods
KW - Middle Aged
KW - Peripheral Arterial Disease/therapy
KW - Quality of Life
KW - Telephone
KW - Treatment Outcome
U2 - 10.3238/arztebl.m2024.0008
DO - 10.3238/arztebl.m2024.0008
M3 - SCORING: Journal article
C2 - 38269534
VL - 121
SP - 323
EP - 330
JO - DTSCH ARZTEBL INT
JF - DTSCH ARZTEBL INT
SN - 1866-0452
IS - 10
ER -
